These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29604074)

  • 1. Effect of four rounds of annual school-wide mass praziquantel treatment for schistosoma mansoni control on schistosome-specific immune responses.
    Ndombi EM; Abudho B; Kittur N; Carter JM; Korir H; Riner DK; Ochanda H; Lee YM; Secor WE; Karanja DM; Colley DG
    Parasite Immunol; 2018 Jun; 40(6):e12530. PubMed ID: 29604074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SCHISTOSOMA MANSONI INFECTION AND THE ASSOCIATED ANTIBODY IMMUNE RESPONSE AMONGST RESIDENTS OF KIGUNGU ENTEBBE, UGANDA.
    Odongo-Aginya EI; Wilson RA; Kyabayinze D; Sempewo H; Oliveira RC; Kironde F
    East Afr Med J; 2012 Apr; 89(4):111-20. PubMed ID: 26856035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increases in levels of schistosome-specific immunoglobulin E and CD23(+) B cells in a cohort of Kenyan children undergoing repeated treatment and reinfection with Schistosoma mansoni.
    Black CL; Muok EM; Mwinzi PN; Carter JM; Karanja DM; Secor WE; Colley DG
    J Infect Dis; 2010 Aug; 202(3):399-405. PubMed ID: 20560767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in IgE- and antigen-dependent histamine-release in peripheral blood of Schistosoma mansoni-infected Ugandan fishermen after treatment with praziquantel.
    Satti MZ; Cahen P; Skov PS; Joseph S; Jones FM; Fitzsimmons C; Hoffmann KF; Reimert C; Kariuki HC; Kazibwe F; Mwatha JK; Kimani G; Vennervald BJ; Ouma JH; Kabatereine NB; Dunne DW
    BMC Immunol; 2004 Apr; 5():6. PubMed ID: 15102330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case Report: Diagnosis and Assessment of Cure Approaches for Acute Schistosomiasis in Pre-School Children.
    Cavalcanti MG; Engel DC; de Araujo Cunha AF; Peralta JM
    Front Immunol; 2021; 12():624736. PubMed ID: 34054799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of treatment on IgE responses against parasite allergen-like proteins and immunity to reinfection in childhood schistosome and hookworm coinfections.
    Pinot de Moira A; Jones FM; Wilson S; Tukahebwa E; Fitzsimmons CM; Mwatha JK; Bethony JM; Kabatereine NB; Dunne DW
    Infect Immun; 2013 Jan; 81(1):23-32. PubMed ID: 23071136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal.
    Gryseels B; Stelma FF; Talla I; van Dam GJ; Polman K; Sow S; Diaw M; Sturrock RF; Doehring-Schwerdtfeger E; Kardorff R
    Trop Geogr Med; 1994; 46(4 Spec No):209-19. PubMed ID: 7825223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Four Years of Annual Mass Drug Administration on Prevalence and Intensity of Schistosomiasis among Primary and High School Children in Western Kenya: A Repeated Cross-Sectional Study.
    Abudho BO; Ndombi EM; Guya B; Carter JM; Riner DK; Kittur N; Karanja DMS; Secor WE; Colley DG
    Am J Trop Med Hyg; 2018 May; 98(5):1397-1402. PubMed ID: 29532768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy-induced, age-related changes in antischistosome antibody responses.
    Mutapi F; Hagan P; Woolhouse ME; Mduluza T; Ndhlovu PD
    Parasite Immunol; 2003 Feb; 25(2):87-97. PubMed ID: 12791104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody isotype responses to Schistosoma japonicum antigens in subjects from a schistosomiasis area with repeated praziquantel chemotherapy compared with a new endemic zone in Hunan Province, P.R. China.
    Li Y; Yu DB; Li YS; Luo XS; Liang YS; Bartley PB; McManus DP
    Trans R Soc Trop Med Hyg; 2002; 96(2):210-5. PubMed ID: 12055818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of praziquantel treatment of Schistosoma mansoni during pregnancy on intensity of infection and antibody responses to schistosome antigens: results of a randomised, placebo-controlled trial.
    Tweyongyere R; Mawa PA; Emojong NO; Mpairwe H; Jones FM; Duong T; Dunne DW; Vennervald BJ; Katunguka-Rwakishaya E; Elliott AM
    BMC Infect Dis; 2009 Mar; 9():32. PubMed ID: 19296834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of morbidity in Schistosoma mansoni-positive primary and secondary school children after four years of mass drug administration of praziquantel in western Kenya.
    Abudho BO; Guyah B; Ondigo BN; Ndombi EM; Ireri E; Carter JM; Riner DK; Kittur N; Karanja DMS; Colley DG
    Infect Dis Poverty; 2020 Jun; 9(1):67. PubMed ID: 32539826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairment of the Schistosoma mansoni-specific immune responses elicited by treatment with praziquantel in Ugandans with HIV-1 coinfection.
    Joseph S; Jones FM; Laidlaw ME; Mohamed G; Mawa PA; Namujju PB; Kizza M; Watera C; Whitworth JA; Dunne DW; Elliott AM
    J Infect Dis; 2004 Aug; 190(3):613-8. PubMed ID: 15243939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early post-treatment immunoglobulin profile in human schistosomiasis.
    Abd El-Aal AA; El-Arousy MH; El-Gendy AM; Tunkul Ael-K; Ismail SA; El-Badry AA
    J Egypt Soc Parasitol; 2005 Apr; 35(1):167-80. PubMed ID: 15881004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of combined praziquantel and recombinant glutathione S-transferase on resistance to reinfection in murine Schistosomiasis mansoni.
    Botros SS; Makary EA; Ahmed KM; Ibrahim AM; Nashed NN; El-Nahal HM; Doughty BL; Hassanein HI
    Int J Immunopharmacol; 2000 Nov; 22(11):979-88. PubMed ID: 11090706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Schistosoma mansoni infection and the therapeutic efficacy of praziquantel among school children in Manna District, Jimma Zone, southwest Ethiopia.
    Bajiro M; Dana D; Ayana M; Emana D; Mekonnen Z; Zawdie B; Garbi A; Kure A; Zeynudin A
    Parasit Vectors; 2016 Oct; 9(1):560. PubMed ID: 27772528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schistosoma mansoni in mice: the pattern of primary cercarial exposure determines whether a secondary infection post-chemotherapy elicits a T helper 1- or a T helper 2-associated immune response.
    Farah IO; Johansson M; Lövgren-Bengtson K; Hau J
    Scand J Immunol; 2000 Mar; 51(3):237-43. PubMed ID: 10736092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age- and sex-related differences in antibody responses against Schistosoma mansoni soluble egg antigen in a cohort of school children in Ethiopia.
    Abebe F; Gaarder PI; Petros B; Gundersen SG
    APMIS; 2001 Dec; 109(12):816-24. PubMed ID: 11846722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of praziquantel and oxamniquine treatment on human isotype responses to Schistosoma mansoni: elevated IgE to adult worm.
    Webster M; Fallon PG; Fulford AJ; Butterworth AE; Ouma JH; Kimani G; Dunne DW
    Parasite Immunol; 1997 Jul; 19(7):333-5. PubMed ID: 9278946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tandem repeat recombinant proteins as potential antigens for the sero-diagnosis of Schistosoma mansoni infection.
    Kalenda YD; Kato K; Goto Y; Fujii Y; Hamano S
    Parasitol Int; 2015 Dec; 64(6):503-12. PubMed ID: 26148816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.